← Back to Search

SPY fluorescent angiography for Ureteral Obstruction

N/A
Waitlist Available
Research Sponsored by University of Virginia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Undergoing open urinary diversion
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1.5 years
Awards & highlights

Study Summary

This trial will compare the rate of ureteroenteric stricture in patients who have had intraoperative use of SPY fluorescent angiography during urinary diversion to historic controls.

Eligible Conditions
  • Ureteral Obstruction
  • Ureter Stricture

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You have recently undergone a surgery to create a new way for urine to leave your body.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1.5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1.5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence of Ureteroenteric Stricture
Secondary outcome measures
90 day postoperative readmission
Rate of hydronephrosis, pyelonephritis, or renal impairment

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Study Arm: SPY fluorescent angiographyExperimental Treatment1 Intervention
Group II: Historic Control Arm: Urinary diversion without the use of SPYActive Control1 Intervention
This arm consists of 215 historic controls who have undergone urinary diversion at UVA from 2015-2020 without the use of SPY fluorescent angiography

Find a Location

Who is running the clinical trial?

University of VirginiaLead Sponsor
750 Previous Clinical Trials
1,239,146 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there currently any opportunities to enroll in this research endeavor?

"According to clinicaltrials.gov, the enrollment for this trial has been concluded as of August 23rd 2021. However, there are over 200 other medical studies actively recruiting patients at present."

Answered by AI
~12 spots leftby Mar 2025